1. The therapeutic responses to I-131 ablation in patients of differentiated thyroid carcinoma complicated with nodular goiter
    H. Chai et al, 2022, Médecine Nucléaire CrossRef
  2. Predictive role of nontumoral sodium iodide symporter activity and preoperative thyroid characteristics in remission process of thyroid cancer patients
    Nilufer Yildirim-Poyraz et al, 2014, Annals of Nuclear Medicine CrossRef
  3. Do BRAFV600E mutation and sodium-iodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma?
    Rania Makboul et al, 2020, Nuclear Medicine Communications CrossRef
  4. Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor
    Haitao Zheng et al, 2018, Oncology Letters CrossRef
  5. The scintigraphic, biodistribution and histopathological evaluation of the effect of experimental 131I administration on the gastrointestinal system and the demonstration of the Na+/I− symporter by immunohistochemistry in rats
    Rahsan Yilmaz et al, 2018, Nuclear Medicine Communications CrossRef
  6. The Role of the NIS (SLC5A5) Gene in Papillary Thyroid Cancer: A Systematic Review
    Rafael Martins de Morais et al, 2018, International Journal of Endocrinology CrossRef
  7. A metabolism-related gene signature for predicting the prognosis in thyroid carcinoma
    Qiujing Du et al, 2023, Frontiers in Genetics CrossRef
  8. Clinical significance of integrin-linked kinase in laryngeal squamous cell carcinoma
    Ping-An Wu et al, 2017, Auris Nasus Larynx CrossRef
  9. CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic review
    Maryam Zarkesh et al, 2022, Cancer Cell International CrossRef
  10. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway
    Xin Chen et al, 2024, Functional & Integrative Genomics CrossRef
  11. Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells
    Idit Dotan et al, 2016, PLOS ONE CrossRef
  12. Combinatorial Effect of Temozolomide and Naringenin in Human Glioblastoma Multiforme Cell Lines
    Megha Gautam et al, 2022, Nutrition and Cancer CrossRef
  13. Effects of BRAFV600E mutation on Na+/I- symporter expression in papillary thyroid carcinoma
    Hong Dong et al, 2016, Journal of Huazhong University of Science and Technology [Medical Sciences] CrossRef
  14. Role of thyroid ultrasound combined with thyroglobulin in the diagnosis of postoperative recurrence of thyroid cancer
    Li Zhang et al, 2019, Minerva Endocrinologica CrossRef
  15. 99mTcO4− scintigraphic detection of follicular thyroid cancer and multiple metastatic lesions: A case report
    CHANG-YIN WANG et al, 2013, Oncology Letters CrossRef
  16. Low-iodine diet before radioactive iodine therapy - to prescribe or not to prescribe
    A. R. Guselnikova et al, 2023, Clinical and experimental thyroidology CrossRef